Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports
出版年份 2021 全文链接
标题
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-20
DOI
10.1007/s00262-021-02938-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy
- (2020) Maria Laura Canale et al. ADVANCES IN THERAPY
- Pericardial effusion due to pembrolizumab-induced immunotoxicity: A case report and literature review
- (2019) Suheil Albert Atallah-Yunes et al. CURRENT PROBLEMS IN CANCER
- Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases
- (2019) Masahiro Yamasaki et al. Frontiers in Oncology
- BRIEF REPORT: Immune checkpoint inhibitor associated pericarditis
- (2019) Mehmet Altan et al. Journal of Thoracic Oncology
- Cardiovascular toxicities associated with immune checkpoint inhibitors
- (2019) Jiun-Ruey Hu et al. CARDIOVASCULAR RESEARCH
- Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors
- (2019) Nicolas Palaskas et al. AMERICAN JOURNAL OF CARDIOLOGY
- Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case report
- (2019) Maiko Asai et al. Immunotherapy
- Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management
- (2019) Chandra K. Ala et al. Current Cardiology Reports
- Pericardial effusion under nivolumab: case-reports and review of the literature
- (2019) Anastasia Saade et al. Journal for ImmunoTherapy of Cancer
- Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab
- (2019) Abdul Moiz Khan et al. Immunotherapy
- Recurrent Pericardial Effusion While Receiving Nivolumab for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature
- (2018) Alexander Vittorio et al. Clinical Lung Cancer
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune-mediated Pericarditis With Pericardial Tamponade During Nivolumab Therapy
- (2018) Daniel V.P. de Almeida et al. JOURNAL OF IMMUNOTHERAPY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Pericardial Tamponade Caused by a Hypersensitivity Response to Tuberculosis Reactivation after Anti–PD-1 Treatment in a Patient with Advanced Pulmonary Adenocarcinoma
- (2017) Yi-Chun Chu et al. Journal of Thoracic Oncology
- Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity
- (2017) Alessandro Inno et al. TUMORI
- Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity
- (2017) Alessandro Inno et al. TUMORI JOURNAL
- Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion
- (2016) Igal Kushnir et al. CARDIOLOGY
- Pericardial effusion with tamponade physiology induced by nivolumab
- (2016) Jennifer Nesfeder et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma
- (2016) Constantin A Dasanu et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy– a report of two cases
- (2016) Bhaskar C. Kolla et al. Journal for ImmunoTherapy of Cancer
- Tumor Immunotherapy Directed at PD-1
- (2012) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started